Clinical Trials on Sexually Transmitted Diseases in United Kingdom

Total 148762 results

St George's, University of London
European Union

Completed

Measuring Responses to Sublingual Antigens

Sexually Transmitted Diseases, Viral

United Kingdom
Cwm Taf University Health Board (NHS)
Cardiff University

Completed

Mycoplasma Species and the Genitourinary System

Sexually Transmitted Diseases, Bacterial

United Kingdom
University of Oxford

Completed

OptiGon - Optimising Laboratory Assays for Immune Responses to Gonococcus

Gonorrhea

United Kingdom
Statens Serum Institut
Imperial College London

Completed

Safety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years

Chlamydia Trachomatis

United Kingdom
University of Sussex
Brighton and Sussex University Hospitals NHS Trust

Active, not recruiting

Patients' Experiences and Perceptions of 3TC/DTG Dual Therapy (the PEDAL Study) (PEDAL)

HIV Infections

United Kingdom
ViiV Healthcare

Completed

Pharmacokinetics and Metabolism of 14 Carbon [14C]-GSK3640254

HIV Infections

United Kingdom
ViiV Healthcare

Completed

Dolutegravir Pediatric Liquid Formulation Study

HIV Infections

United Kingdom
Imperial College London
Pfizer

Completed

The Maraviroc Central Nervous System (CNS) Study

HIV Infections

United Kingdom
International AIDS Vaccine Initiative

Completed

Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine

HIV Infections

United Kingdom
Gilead Sciences

Completed

ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla (ONCE)

HIV Infections

United Kingdom
Royal Free Hampstead NHS Trust
Roche Pharma AG

Completed

Lopinavir Capsules to Kaletra or Invirase Tablets (LoCKIT)

HIV Infections

United Kingdom
Queen Mary University of London
National Cancer Institute (NCI)

Recruiting

HPV Self-testing in Transgender Individuals (Self-TI)

HPV Infection

United Kingdom
Cwm Taf University Health Board (NHS)
Cardiff University

Completed

UROGEN WELL D-ONE : Evaluation of a Novel Diagnostic for Sexually Transmitted Bacterial Infections

Sexually Transmitted Diseases, Bacterial | Antimicrobial Resistance | Bacterial Urinary Tract Infection

United Kingdom
St George's, University of London

Completed

Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease (POPI)

Chlamydia Infections | Pelvic Inflammatory Disease

United Kingdom
ViiV Healthcare

Completed

A Study to Compare the Relative Bioavailability of Two Different Formulations of GSK3640254

HIV Infections

United Kingdom
Medicines Development for Global Health
Imperial College London; Phillip T. and Susan M. Ragon Foundation

Terminated

A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People

HIV Infections

United Kingdom
St Stephens Aids Trust

Terminated

Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens

HIV Infections

United Kingdom
Gilead Sciences

Completed

Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers

HIV Infections

United Kingdom
Imperial College London
Wellcome Trust; National Institute for Health Research, United Kingdom

Completed

The Safety and Immunogenicity of a Potential HIV Vaccine

HIV Infections

United Kingdom
Imperial College London

Completed

The Raltegravir and Ribavirin Pharmacokinetics (PK) Study

HIV Infections

United Kingdom
University College, London
King's College London

Unknown

Regional Bone Turnover Using 18F-fluoride-PET/CT in HIV-1-infected Men: PETRAM Study (PETRAM)

HIV Infections

United Kingdom
Hoffmann-La Roche

Completed

A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients

HIV Infections

United Kingdom
Kirby Institute

Completed

Pharmacokinetics of Lamivudine at Two Different Doses (ENCORE2)

HIV Infections

United Kingdom
St Stephens Aids Trust

Completed

Double Protease Inhibitor to Darunavir Switch Study

HIV Infections

United Kingdom
St Stephens Aids Trust

Completed

Maraviroc 300 mg Twice Daily in HIV Negative Male Volunteers

HIV Infections

United Kingdom
St Stephens Aids Trust

Completed

Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects

HIV Infections

United Kingdom
St Stephens Aids Trust

Completed

TMC 125 Blood Levels Study

HIV Infections

United Kingdom
St Stephens Aids Trust

Completed

Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA.

HIV Infection

United Kingdom
Imperial College London

Terminated

The First Failure Study (FAST)

HIV Infections | HIV

United Kingdom
St Stephens Aids Trust

Withdrawn

Depot Contraception With and Without Lopinavir/Ritonavir

HIV Infection

United Kingdom
St Stephens Aids Trust

Completed

The Pharmacology/Aging Clinic (SSAT041)

HIV Infection

United Kingdom
St Stephens Aids Trust

Completed

Atripla to Raltegravir Switch Study for CNS Toxicity (SSAT036)

HIV Infection

United Kingdom
St Stephens Aids Trust

Unknown

Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART) (SSAT039)

HIV Infection

United Kingdom
St Stephens Aids Trust

Completed

PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen (SSAT033)

HIV Infection

United Kingdom
Guy's and St Thomas' NHS Foundation Trust

Completed

Time to Protection and Adherence Requirements of Raltegravir With or Without Lamivudine in Protection From HIV Infection (R-PrEP)

Hiv

United Kingdom
St George's, University of London

Unknown

Study of Single IV Administration of P2G12 (FuturePharma)

HIV Infection

United Kingdom
St Stephens Aids Trust

Completed

Atazanavir/Ritonavir and Zinc Pharmacokinetic Study (SSAT043)

HIV Infection

United Kingdom
St Stephens Aids Trust

Completed

Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study

HIV Infections | HIV

United Kingdom
GlaxoSmithKline

Completed

Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects

HIV Infection

United Kingdom
St George's, University of London
European Union

Completed

Reactogenicity and Immunogenicity of Cervico-vaginal CN54gp140-hsp70 Conjugate Vaccine (TL01)

HIV Infections

United Kingdom
Imperial College London
Boehringer Ingelheim

Completed

The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects

HIV Infections

United Kingdom
Rational Vaccines Inc

Completed

A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease

Patient Engagement | Genital Herpes

United Kingdom
International AIDS Vaccine Initiative
National Institute of Allergy and Infectious Diseases (NIAID); Children's Hospital...

Unknown

A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.

HIV Infections

United Kingdom
Imperial College London
The Hypertension Trust

Completed

A Study to Explore the Association Between Blood Pressure, HIV and Antiretroviral Therapy

HIV Infections

United Kingdom
St George's, University of London
Novartis Vaccines; European Union; Richmond Pharmacology Limited

Terminated

Safety Study Of Nasal HIV Vaccine Adjuvanted With LTK63

HIV Infections

United Kingdom
The Leeds Teaching Hospitals NHS Trust

Recruiting

Meatal Swab Yourself With Testing for Infections Collectively (MYSTIC)

Chlamydia | Gonorrhea

United Kingdom
London School of Hygiene and Tropical Medicine

Active, not recruiting

Transcriptomic and Next Generation Sequencing Approaches to Infection With Treponema Pallidum

Syphilis

United Kingdom
University of Bristol

Completed

Partner Notification for Chlamydia in Primary Care

Chlamydia Infections

United Kingdom
Ardea Biosciences, Inc.

Completed

Naïve HIV POC Monotherapy Trial

HIV Infections

Germany, United Kingdom
International AIDS Vaccine Initiative
University of Nairobi; Medical Research Council-Oxford

Completed

A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers

HIV Infections

United Kingdom, Kenya

Clinical Trials on Sexually Transmitted Diseases in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations